top of page

Apply to an Akros Project

Akros partners with experienced healthcare experts and consultants to support client projects across reimbursement, coding, market strategy, research, and other specialized areas. Browse our current opportunities below and submit your interest for any project that aligns with your experience.

​

New projects are added as needs arise, so check back regularly for additional opportunities.

Accepting Proposals

Migraine Economic Burden and Business Case Research

Assess the economic burden of migraine in the U.S. and develop a defensible research approach to support payer, employer, advocacy, and policy decisions, including opportunities for earlier identification and more appropriate care.

Expected Start Date

N/A

Actuarial

Assigned - Applications Closed

Novel Therapeutic Ultrasound Reimbursement Assessment

Support Akros in assessing coding, coverage, and reimbursement strategy for a non-invasive ultrasound platform for chronic low-back pain, including code applicability, payer requirements, provider economics, and alternative pathways if existing codes are not viable.

Expected Start Date

N/A

​

Accepting Proposals

MRI-Guided TMS Software

Support Akros in evaluating coding, billing, coverage, and reimbursement pathways for fMRI-based software that guides TMS treatment for depression, including whether the targeting functionality can be separately reimbursed.

Expected Start Date

October 2026

​

Assigned - Applications Closed

Pediatric Respiratory Device Coding Assessment

Support Akros in evaluating coding and reimbursement pathways for an early-stage pediatric respiratory medical device, including existing code fit, commercialization implications, and potential new-code options.

Expected Start Date

N/A

​

Accepting Proposals

U.S. Reimbursement & Commercialization Strategy

Support Akros in defining the most viable U.S. reimbursement and commercialization pathway for an FDA-cleared AI-enabled diagnostic technology, including buyer incentives, evidence needs, payment options, and a phased go-to-market roadmap.

Expected Start Date

Before EOY 2026

​

bottom of page